IL6 and infection: Remarkably, by day 14 PI GW9662 treated mice had sustained the stark increase in IL-6 while simultaneously expressing significantly elevated levels of colonic TGF-β and IL-17 further suggesting a Th17 effector response late during infection (Figure 3F–H).